Advancing frameless stereotactic navigation for precise targeting of the foramen ovale during radio-frequency thermal ablation (RFTA) for trigeminal neuralgia in anesthetized patients using triggered electromyography - Scorecard - MDSpire

Advancing frameless stereotactic navigation for precise targeting of the foramen ovale during radio-frequency thermal ablation (RFTA) for trigeminal neuralgia in anesthetized patients using triggered electromyography

  • By

  • Justin W. Silverstein

  • Alon Kashanian

  • Grace Huang

  • Jason A. Ellis

  • June 5, 2025

  • 0 min

Share

Clinical Scorecard: Enhancing frameless stereotactic guidance for accurate targeting of the foramen ovale during radio-frequency thermal ablation for trigeminal neuralgia in sedated patients utilizing triggered electromyography

At a Glance

CategoryDetail
ConditionTrigeminal neuralgia (TN), a neuropathic facial pain disorder
Key MechanismsUse of triggered electromyography (T-EMG) combined with stereotactic navigation and fluoroscopy to dynamically map the V3 motor branch for precise foramen ovale (FO) cannulation during radio-frequency thermal ablation (RFTA)
Target PopulationPatients with trigeminal neuralgia including classic, secondary, idiopathic TN, and persistent idiopathic facial pain undergoing RFTA under general anesthesia
Care SettingSurgical setting with intraoperative neurophysiology support in a specialized neurosurgical center

Key Highlights

  • RFTA is preferred for TN patients with prior microvascular decompression, multiple sclerosis, or trigeminal nerve damage.
  • Traditional awake RFTA relies on patient feedback, which can be unreliable and uncomfortable; T-EMG allows guidance under general anesthesia.
  • The novel technique achieved 96% success in FO cannulation with intact mastication post-procedure and 61.5% of patients reporting pain improvement.

Guideline-Based Recommendations

Diagnosis

  • Classify TN according to International Classification of Headache Disorders (ICHD-3) into classic, secondary, idiopathic TN, or persistent idiopathic facial pain.

Management

  • Consider RFTA for patients with TN, especially those with prior MVD, MS, or nerve damage.
  • Utilize frameless stereotactic navigation combined with triggered EMG for accurate FO targeting during RFTA under general anesthesia.

Monitoring & Follow-up

  • Intraoperative neurophysiological monitoring using T-EMG to detect compound muscle action potentials (CMAP) from the masseter muscle.
  • Adjust stimulation intensity to submaximal activation to confirm FO cannulation and guide electrode trajectory.

Risks

  • Potential intraoperative complications include damage to cranial nerves III, IV, VI, carotid artery injury, and mastication weakness.
  • Anatomical variations and calcification of FO, especially in elderly patients, may complicate cannulation and increase risk of RFTA failure.

Patient & Prescribing Data

26 patients (17 females, 9 males) aged 24-79 years with various TN subtypes undergoing 27 RFTA procedures.

96% success in FO cannulation using T-EMG guidance; median stimulus intensity 4.5 mA; 61.5% experienced pain improvement; all patients retained mastication function post-procedure.

Clinical Best Practices

  • Place needle electrodes in the masseter muscle prior to incision for T-EMG monitoring.
  • Convert Tew trigeminal needle stylet into a monopolar stimulation probe using an alligator clip connected to a neuromonitoring system.
  • Use stereotactic navigation and fluoroscopy to guide needle to FO border, confirming location by eliciting CMAP in masseter muscle at submaximal stimulation.
  • Advance needle through FO toward Gasserian ganglion with continuous stimulation to differentiate nerve branches and target specific divisions (e.g., V2).
  • Perform RFTA under general anesthesia with intraoperative neurophysiology to improve patient comfort and procedural accuracy.

References

Original Source(s)

Related Content